Miller Michael Patrick

Miller Michael Patrick is listed in filings as Director at Rigel Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Rigel Pharmaceuticals, Inc. (RIGL), BioXcel Therapeutics, Inc. (BTAI), and Puma Biotechnology, Inc. (PBYI). The current snapshot covers public activity from Jun 11, 2024 to May 19, 2026. Reported amounts are shown as $418.3K to $97.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.